Making it in Manufacturing cover art

All Episodes

Making it in Manufacturing — 29 episodes

#
Title
1

How Samsung Biologics Is Redefining CDMO Partnerships - John Gagliardi

2

We Just Built a $1.5B Biologics Company… And We're Here to Disrupt the Industry - Joon Chang

3

From Lab Scientist to Pharma Leader: 40 Years of Scaling and Strategy Insight - Alison Clayton

4

This CDMO Has an Advantage No One Else Can Replicate - Quotient Sciences

5

The Hidden Challenges of Biologics Development - Dr. Adriana Kiędzierska-Mencfeld

6

Why CDMOs Must Scale Smarter - Peter Belden

7

Building a Pharma Company Is Harder Than You Think - David Stevens

8

The Hidden Challenges of Biologics Development - Dr. Adriana Kiędzierska-Mencfeld

9

This Model Could Replace Traditional CDMOs

10

The Truth About Automation in Modern Biomanufacturing - Daniel Shearer, FujiFilm

11

The Relentless Mindset Behind Scaling a Drug Manufacturing Company | Philippe Clavel

12

How Pharma Actually Sets Global Standards (GAMP Explained)

13

How Xellia Is Reshaping Europe’s Antibiotics Market | CEO Michael Kocher

14

The Untold Reality of Scaling Global Pharma Manufacturing - Xellia Pharmaceuticals

15

Inside Mabion’s Growth Strategy | CEO Gregor Kawaletz on Biosimilars & Biologics

16

Building Trust in Pharma and Biotech Manufacturing Partnerships | Sharp Services

17

What Makes a CDMO Investable? Ankit Gupta on Building Instapill for Long-Term Growth

18

Redefining Biomanufacturing: Himanshu Gadgil on Enzene’s Global CDMO Expansion

19

Scaling a Legacy CDMO: Inside Pyramid Pharma’s Fill-Finish Expansion

20

$45M Expansion: What’s Next for Argonaut’s Aseptic Manufacturing Capabilities

21

The CDMO Changing Oral Drug Delivery – Instapill CEO Ankit Gupta

22

How ten23 Became One of Europe’s Fastest-Growing Drug-Product CDMOs

23

How Do You Successfully Scale and Integrate CDMO Sites After Acquisition? J.D. Mowery

24

How a Crack in Equipment Taught Abbas Hussain the Value of Planning Buffers

25

How Michael Vrijs Defends His Site Against Auditors - Without Saying Too Much

26

Carsten Jasper: Revolutionising Pharma Compliance with AI, Cleanrooms & Bold Thinking

27

Simon Adams: Building Organisations That Can Withstand Change

28

Hazem Eleskandarani: Engineering Excellence in Global Pharmaceutical Quality

29

Hilary Mills-Baker: Championing Quality and Innovation in Life Sciences Automation